China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • 6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy

    6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy

    6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy is the intermediate of Cyproterone acetate.

    CAS:17183-98-1

  • Oxcarbazepine

    Oxcarbazepine

    Oxcarbazepine has CP, EP and USP specifications. CEP and DMF available, GMP approved.

    CAS:28721-07-5

  • Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3
    Specifications:0.2mg*3
    Indications:Abortion
  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • Flumethasone

    Flumethasone

    Flumethasone is a glucocorticoid, an anti-inflammatory. It can promptly decrease inflammation, exudation and itching is experienced after application.

    CAS:2135-17-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept